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patients: Results from the Veterans Affairs National Surgical Quality
Improvement Program
R.L. Bush, M.L. Johnson, N. Hedayati, W.G. Henderson, P.H. Lin and
A.B. Lumsden
Objective. Recent results after endovascular abdominal aortic aneurysm
repair (EVAR) have brought into question its value in patients deemed at
high-risk for surgical intervention. The Department of Veteran Affairs (VA)
National Surgical Quality Improvement Program (NSQIP) is the largest pro-
spectively collected and validated United States surgical database represent-
ing current clinical practice. The purpose of our study was to evaluate
outcomes after elective EVAR performed in high-risk veterans.
Methods. Using NSQIP data from 123 participating VA hospitals, we retro-
spectively evaluated patients who underwent elective aneurysm repair
from May 2001 to December 2004. High-risk criteria were used to identify
a cohort for analysis (EVAR, n ¼ 788; open, n ¼ 1580). High-risk criteria an-
alyzed included age 60 years, American Society of Anesthesiology (ASA)
classification 3 or 4, and the comorbidity variables of history of cardiac, respi-
ratory, or hepatic disease, cardiac revascularization, renal insufficiency, and
low serum albumin level. Our primary end points were 30-day and 1-year
all-cause mortality, and we evaluated a secondary end point of perioperative
complications. Statistical analysis included univariate analysis and multivar-
iate modeling.
Results. Veterans who were classified as high-risk underwent elective EVAR
with significantly lower 30-day (3.4% vs 5.2%, P ¼ .047) and 1-year all-cause
mortality (9.5 % vs 12.4%, P ¼ .38) than patients having open repair. EVAR
was associated with a decrease in 30-day postoperative mortality (adjusted
odds ratio [OR], 0.65; 95% confidence interval [CI], 0.42 to 1.03; P ¼ .067) as
well as 1-year mortality (adjusted OR, 0.68; 95% CI, 0.51 to 0.91; P ¼ .0094)
despite the presence of severe comorbid conditions. The risk of perioperative
complications was significantly lower after EVAR (16.2% vs 31.0%; P < .0001;
adjusted OR, 0.41; 95% CI, 0.33 to 0.52; P < .0001). A subset analysis of higher-
risk patients (ASA 4 and the above comorbidity variables) still demonstrated
an acceptable 30-day mortality rate.
Conclusion. In veterans deemed high-risk for surgical therapy, outcomes
after elective EVAR are excellent, and the procedure is relatively safe in
this special patient population. Our retrospective data demonstrate that pa-
tients with considerable medical comorbidities and infrarenal abdominal
aortic aneurysms benefit from and should be considered for primary
EVAR.
Initial results of wireless pressure sensing for endovascular aneurysm
repair: The APEX TrialdAcute Pressure Measurement to Confirm
Aneurysm Sac EXclusion
T. Ohki, K. Ouriel, P.G. Silveira, B. Katzen, R. White, F. Criado and
E. Diethrich
Objective. Complete exclusion and depressurization of the aneurysm sac is
the prime goal of endovascular repair (EVAR) of abdominal aortic aneu-
rysms. Thus, any EVAR that results in a type I or III endoleak has been clas-
sified as a technical failure. The current method to detect endoleaks uses
intraoperative aortography. However, aortography is limited by its subjective
nature, inability to quantify the significance of the endoleak, and artifacts
such as bowel gas that may mimic an endoleak. In addition, repetitive con-
trast injection may impair renal function. To increase the efficacy and safety
of intraoperative endoleak detection, a wireless pressure-monitoring system
has been developed and tested in the clinical setting.
Methods. The APEX trial (Acute Pressure Measurement to Confirm Aneu-
rysm Sac EXclusion) is a prospective, multicenter/international trial
sponsored by CardioMEMS to evaluate the safety and efficacy of the
* Full articles available online at www.jvascsurg.orgYEJVS2457_2429_proof  1
1078e5884/000251+ 03 $32.00/0  2007 Published by Elsevier Ltd.EndoSure wireless pressure sensor for EVAR. The 30  5  1.5-mm sensor
contains no battery and is powered externally with radiofrequency energy.
The sensors are extremely stable, operate over the full physiologic range of
pressures, and have a resolution of 1 mm Hg. A total of 90 patients were
enrolled at 12 sites, 76 of whom were eligible for analysis. The sensor
was implanted via the contralateral femoral artery at the time of EVAR.
The sac pulse pressure was measured with both an angiographic catheter
and the sensor after deployment of the main endograft but before the
deployment of the contralateral limb (type I endoleak equivalent). Sac
pressure was again measured with the sensor after deployment of the
contralateral limb and completion of the EVAR. Data were collected in a pro-
spective manner.
Results. In all of the eligible patients (n ¼ 76), the initial sensor pressure
measurement agreed closely with the angiographic catheter pressure mea-
surement of the type I endoleak equivalent. At the completion of the pro-
cedure, there was agreement between the sensor measurement and
angiography regarding the presence or absence of a type I or III endoleak
in 92.1% (n ¼ 70) of the measurements. Overall, the sensitivity was 0.94
and the specificity was 0.80 for detecting type I or III endoleaks.
Final pulse pressures decreased significantly compared with baseline
measurements.
Conclusions. Implantation of the wireless pressure sensor is safe, and remote
aneurysm sac pressure sensing is feasible. It was a valuable guide in evaluat-
ing the completeness of the EVAR procedure. Long-term study will be
needed to prove its efficacy for postoperative surveillance.
Retrograde mesenteric stenting during laparotomy for acute occlusive
mesenteric ischemia
M.C. Wyers, R.J. Powell, B.W. Nolan and J.L. Cronenwett
Introduction. Acute mesenteric ischemia (AMI) due to arterial occlusive dis-
ease requires prompt diagnosis and revascularization in order to avoid the
high mortality associated with this disease. In an attempt to minimize the
magnitude of operation for arterial occlusive AMI, we have developed
a new technique of endovascular recanalization and open retrograde stenting
of the superior mesenteric artery (SMA) during laparotomy, so that the bowel
can also be assessed and resected if necessary.
Methods. All emergent mesenteric revascularizations for arterial occlusive
AMI performed at Dartmouth-Hitchcock Medical Center from 2001e2005
(n¼13) were retrospectively reviewed. Outcomes were analyzed with respect
to the method of revascularization and other perioperative variables. Reste-
nosis was evaluated with duplex ultrasound.
Results. Three different revascularization methods were used: surgical
bypass (n¼5), antegrade, percutaneous stenting (n¼2), and retrograde open
mesenteric (SMA) stenting (ROMS, n¼6). Satisfactory revascularization was
achieved in all cases and all methods. ROMS was successfully accomplished
in 3 of 6 patients after antegrade attempts to cross the SMA from the arm
were unsuccessful. Hospital mortality was lowest in the ROMS group
(17%) compared to the other groups e bypass, 80% (p¼0.08) and percutane-
ous stent 100% (p¼0.11). All 5 of the surviving patients treated with ROMS
were able to be discharged to home after a mean hospital stay of 20 days
(range 6e38 days). During a mean follow-up of 13  7 months, 3 patients
died of unrelated causes, of which 2 were being followed with asymptomatic
recurrent SMA stenosis detected by duplex scan. The 2 surviving patients are
alive and well, but one has required percutaneous SMA stenting of a progres-
sive asymptomatic restenosis.
Conclusion. Retrograde open SMA stenting during laparotomy for AMI has
a high technical success rate and provides an attractive alternative to surgical
bypass in these often critically ill patients. Because it is combined with open
laparotomy, it honors the essential surgical principles of evaluating and re-
secting nonviable bowel. Restenosis rates appear to be high so that patients
must be followed closely. Further study and development of this new hybrid
technique is warranted.3 January 2007  251/253
252 AbstractsThe endovascular management of visceral artery aneurysms and
pseudoaneurysms
N. Tulsyan, V.S. Kashyap, R.K. Greenberg, T.P. Sarac, D.G. Clair, G. Pierce
and K. Ouriel
Objective. Visceral artery aneurysms may be treated by aneurysm exclusion,
excision, revascularization, and endovascular techniques. The purpose of this
study was to review the outcomes of the management of visceral artery
aneurysms with catheter-based techniques.
Methods. Between 1997 and 2005, 90 patients were identified with a diagnosis
of visceral artery aneurysm. This was inclusive of aneurysmal disease of the
celiac axis, superior mesenteric artery (SMA), inferior mesenteric artery, and
their branches. Surveillance without intervention occurred in 23 patients, and
19 patients underwent open aneurysm repair (4 ruptures). The endovascular
treatment of 48 consecutive patients (mean age 58, 60% men) with 20 visceral
artery aneurysms (VAA) and 28 visceral artery pseudoaneurysms (VAPA)
was the basis for this study. Electronic and hardcopy medical records were
reviewed for demographic data and clinical variables. Original computed
tomography (CT) scans and fluoroscopic imaging were evaluated.
Results. The endovascular treatment of visceral artery aneurysms was tech-
nically successful in 98% of 48 procedures, consisting of 3 celiac axis repairs,
2 left gastric arteries, 1 SMA, 12 hepatic arteries, 20 splenic arteries, 7 gastro-
duodenal arteries, 1 middle colic artery, and 2 pancreaticoduodenal arteries.
Of these, 29 (60%) were performed for symptomatic disease (5 ruptured an-
eurysms). Procedures were performed in the endovascular suite under local
anesthesia with conscious sedation (94%). The femoral artery was used as the
preferential access site (90%). Coil embolization was used for aneurysm ex-
clusion in 96%. N-butyl-2-cyanoacrylate (glue) was used selectively (19%) us-
ing a triaxial system with a 3F microcatheter for persistent flow or multiple
branches. The 30-day mortality was 8.3% (n ¼ 4). One patient died from re-
current gastrointestinal bleeding after gastroduodenal embolization, and the
remaining died of unrelated causes. All perioperative deaths occurred in pa-
tients requiring urgent or emergent intervention in the setting of hemody-
namic instability. No patients undergoing elective intervention died in the
periprocedural period. Postprocedural imaging was performed after 77% of
interventions at a mean of 16 months. Complete exclusion of flow within
the aneurysm sac occurred in 97% interventions with follow-up imaging,
but coil and glue artifact complicated CT evaluation. Postembolization syn-
drome developed in three patients (6%) after splenic artery embolization.
There was no evidence of hepatic insufficiency or bowel ischemia after either
hepatic or mesenteric artery aneurysm treatment. Three patients required sec-
ondary interventions for persistent flow (n ¼ 1) and recurrent bleeding from
previously embolized aneurysms (n ¼ 2).
Conclusion. Visceral artery aneurysms and pseudoaneurysms can be success-
fully treated with endovascular means with low periprocedural morbidity;
however, the urgent repair of these lesions is still associated with elevated
mortality rates. Aneurysm exclusion can be accomplished with coil emboliza-
tion and the selective use of N-butyl-2-cyanoacrylate. Current catheter-based
techniques extend our ability to exclude visceral artery aneurysms, but imag-
ing artifact hampers postoperative CT surveillance.
Gender-associated differences in plaque phenotype of patients
undergoing carotid endarterectomy
W.E. Hellings, G. Pasterkamp, B.A.N. Verhoeven, D.P.V. De Kleijn, J.-P.P.M.
De Vries, K.A. Seldenrijk, T. van den Broek and F.L. Moll
Background. Carotid endarterectomy to prevent a stroke is less beneficial for
women compared with men. This benefit is lower in asymptomatic women
compared with asymptomatic men or symptomatic patients. A possible ex-
planation for this gender-associated difference in outcome could be found
in the atherosclerotic carotid plaque phenotype. We hypothesize that women,
especially asymptomatic women, have more stable plaques than men, result-
ing in a decreased benefit of surgical plaque removal.
Methods. Carotid endarterectomy specimens of 450 consecutive patients (135
women, 315 men) were studied. The culprit lesions were semi-quantitatively
analyzed for the presence of macrophages, smooth muscle cells, collagen,
calcifications and luminal thrombus. Plaques were categorized in three pheno-
types according to overall presentation and the amount of fat. Protein was
isolated from the plaques for determination of interleukin-6 (IL-6) and IL-8
concentrations andmatrixmetalloproteinase-8 (MMP-8) andMMP-9 activities.Eur J Vasc Endovasc Surg Vol 33, February 2007Results. Atheromatous plaques (>40% fat) were less frequently observed in
women than in men (22% vs 40%; P < .001). In addition, plaques obtained
from women more frequently revealed low macrophage staining (11% vs
18%; P ¼ .05) and strong smooth muscle cell staining (38% vs 24%; P ¼
.001). Compared with men, women had a lower plaque concentration of
IL-8 (P ¼ .001) and lower MMP-8 activity (P ¼ .01). The observed differences
were most pronounced in asymptomatic women, who showed the most sta-
ble plaques, with an atheromatous plaque in only 9% of cases compared with
39% in asymptomatic men (P ¼ .02). In addition, a large proportion of plaques
obtained from asymptomatic women showed high smooth muscle cell
content (53% vs 30%; P ¼ .03) and high collagen content (55% vs 24%;
P ¼ .003). All relations between gender and plaque characteristics, except
for MMP-8, remained intact in a multivariate analysis, including clinical
presentation and other cardiovascular risk factors.
Conclusion. Carotid artery plaques obtained from women have a more
stable, less inflammatory phenotype compared with men, independent of
clinical presentation and cardiovascular risk profile. Asymptomatic women
demonstrate the highest prevalence of stable plaques. These findings could
explain why women benefit less from carotid endarterectomy compared
with men.
A comparison of percutaneous transluminal angioplasty versus
amputation for critical limb ischemia in patients unsuitable for open
surgery
S.M. Taylor, C.A. Kalbaugh, D.W. Blackhurst, D.C. Kellicut, E.M. Langan III
and J.R. Youkey
Background. Percutaneous transluminal angioplasty (PTA), although not the
traditional therapy, seems to be a safe alternative for patients with critical
limb ischemia who are believed to be unsuitable candidates for open surgery.
However, the efficacy of PTA in this setting has not been analyzed. The pur-
pose of this study was to compare the outcomes of PTA for limb salvage with
outcomes of major limb amputation in physiologically impaired patients
believed to be unsuitable for open surgery.
Methods. From a prospective vascular registry, 314 patients (183 under-
went amputation, and 131 underwent complex PTA for limb salvage)
were identified as physiologically impaired or unsuitable for open surgery.
This was defined as having at least one of the following: functional im-
pairment (homebound ambulatory or transfer only), mental impairment
(dementia), or medical impairment (two of the following: end-stage renal
disease, coronary artery disease, and chronic obstructive pulmonary dis-
ease). Patients undergoing PTA were compared with patients undergoing
amputation by examining the outcome parameters of survival, mainte-
nance of ambulation, and maintenance of independent living status.
Parameters were assessed by using Kaplan-Meier life-table curves (log-
rank test and 95% confidence intervals [CIs]) and hazard ratios (HRs)
from the Cox model.
Results. PTA resulted in a 12-month limb salvage rate of 63%. Thirty-day
mortality was 4.4% for the amputation group and 3.8% for the PTA group.
After adjustment for age, race, diabetes, prior vascular procedure, dementia,
and baseline functional status, PTA patients had significantly lower rates of
ambulation failure (HR, 0.44; P ¼ .0002) and loss of independence (HR,
0.53; P ¼ .025) but had significantly higher mortality (HR, 1.62; P ¼ .006)
than amputees. However, when life tables were examined, the maintenance
of ambulation advantage lasted only 12 months (PTA, 68.6%; 95% CI,
59.6%e77.7%; amputation, 48%; 95% CI, 40.4%e55.5%) and was not statisti-
cally significant at 2 years (62.2% [95% CI, 48.8%e71.5%] and 44% [95% CI,
35.8%e52.2%], respectively). Maintenance of independent living status ad-
vantage lasted only 3 months, with no statistically significant difference at
2 years (PTA, 60.5%; 95% CI, 45.4%e75.6%; amputation, 52.6%; 95% CI,
40.4%e64.9%). Although mortality was high in both cohorts, patients who
underwent amputation had a survival advantage for all time intervals exam-
ined (at 2 years: PTA, 29%; 95% CI, 19.9%e38.1%; amputation, 48.1%; 95% CI,
39.2%e56.9%).
Conclusions. Patients who present with critical limb ischemia and physio-
logic impairments that preclude open surgery seem to have comorbidities
that blunt any functional advantage achieved after PTA for limb salvage. PTA
in this setting affords very little benefit compared with amputation alone.
253AbstractsPaget-Schroetter syndrome treated with thrombolytics and immediate
surgery
J.E. Molina, D.W. Hunter and C.A. Dietz
Introduction. Reviewed are the results of the emergent treatment of effort
thrombosis of the subclavian vein. The protocol calls for immediate throm-
bolysis, followed by surgery at the time of the acute event. The one-stage pro-
cedure includes decompression of the thoracic inlet by subclavicular removal
of the first rib, subclavius muscle, scalenectomy, and vein patch plasty of the
stenotic segment of the vein.
Methods. Between July 1985 through June 2006, 114 patients presented with
Paget-Schroetter syndrome (effort thrombosis of the subclavian vein), 97 of
which (group I) were seen 2 weeks of onset of symptoms. They underwent
an emergent protocol treatment in which thrombolysis is immediately fol-
lowed by surgery at the time of the acute event. In addition, another 17
patients (group II) were referred to our institution after being treated else-
where with initial thrombolysis, but with surgery deferred a mean 34 days
(range, 2 weeks to 3 months) after the initial event. All patients underwent
the same lytic and surgical protocol. Operability was determined by the find-
ings on the venogram. Routine postoperative anticoagulation for 8 weeks was
implemented with warfarin and clopidogrel.
Results. There was 100% success in re-establishing the flow and normal
caliber of the subclavian vein in the 97 patients in group I. Seven patients
showed some residual stenosis that required balloon plasty and implant of
a stent. Postoperative duplex ultrasound imaging documented patency in
all 97 patients (100%). The 17 patients with delayed surgery (group II)
showed progression of the fibrosis, with vein obstruction in 12 (70%).
Only five patients (29%) were operable with successful results. The
remaining 12 patients were inoperable owing to extensive fibrosis and
occlusion of the inflow, and all 12 have remained disabled for the use
of their arm.
Conclusions. The emergent approach to treat Paget-Schroetter syndrome
seems to render the optimal results, with 100% effectiveness in re-establishing
venous flow and normal caliber to the vessel. When properly conducted, this
operation avoids the use of stents or balloon plasty with excellent long-term
results, leaving the patients unrestricted for physical activities.Laboratory-based vascular anastomosis training: A randomized
controlled trial evaluating the effects of bench model fidelity and level
of training on skill acquisition
R.S. Sidhu, J. Park, R. Brydges, H.M. MacRae and A. Dubrowski
Background. Although there is growing evidence that practice on bench
model simulators can improve the acquisition of technical skill in surgery,
the degree to which these models have to approximate real-world conditions
(model fidelity) to optimize learning is unclear. Previous research suggests
that low-fidelity models may be adequate for novice learners. The purpose
of this study was to assess the effect of model fidelity and surgical expertise
on the acquisition of vascular anastomosis skill.
Methods. Twenty-seven surgical residents participated in this institutional re-
view boardeapproved study. Junior residents (postgraduate year 1 and 2)
and senior residents (postgraduate year 4 or higher) were randomized into
two groups: low-fidelity (n ¼ 13) and high-fidelity (n ¼ 14) model training.
Both groups were given a 3-hour hands-on training session: the low-fidelity
group used plastic models, and the high-fidelity group used human cadaver
arms (brachial arteries) to practice graft-to-arterial anastomosis. One week
later, all subjects participated in an animal laboratory in which they per-
formed a single vascular anastomosis on a live, anesthetized pig (femoral
artery). A blinded vascular surgeon scored candidate performance in the
animal laboratory by using previously validated end points, including a
checklist and final product analysis score.
Results. Acquisition of skill was significantly affected by model fidelity and
level of training as measured by both the checklist (P ¼ .03) and final product
analysis (P ¼ .01; Kruskal-Wallis). Specifically, junior residents practicing on
high-fidelity models scored better on the checklist (P ¼ .05) and final product
analysis (P ¼ .04). Senior residents practicing on high-fidelity models scored
better on final product analysis (P < .05).
Conclusions. Training in the laboratory does improve skill when assessed in
a realistic setting. Both expertise groups showed better skill transfer from the
bench model to live animals when practicing on high-fidelity models. For
vascular anastomosis, it is important to provide appropriate model fidelity
for trainees of different abilities to optimize the effectiveness of bench model
training.Eur J Vasc Endovasc Surg Vol 33, February 2007
